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Abstract
Lujo virus (LUJV), a new member of the family Arenaviridae and the first hemorrhagic fever–associated arenavirus from the
Old World discovered in three decades, was isolated in South Africa during an outbreak of human disease characterized by
nosocomial transmission and an unprecedented high case fatality rate of 80% (4/5 cases). Unbiased pyrosequencing of RNA
extracts from serum and tissues of outbreak victims enabled identification and detailed phylogenetic characterization
within 72 hours of sample receipt. Full genome analyses of LUJV showed it to be unique and branching off the ancestral
node of the Old World arenaviruses. The virus G1 glycoprotein sequence was highly diverse and almost equidistant from
that of other Old World and New World arenaviruses, consistent with a potential distinctive receptor tropism. LUJV is a
novel, genetically distinct, highly pathogenic arenavirus.
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Introduction
Members of the genus Arenavirus, comprising currently 22
recognized species (http://www.ictvonline.org/virusTaxonomy.
asp?version=2008), are divided into two complexes based on
serologic, genetic, and geographic relationships [1,2]: the New
World (NW) or Tacaribe complex, and the Old World (OW) or
Lassa-Lymphocytic choriomeningitis complex that includes the
ubiquitous arenavirus type-species Lymphocytic choriomeningitis virus
(LCMV; [3]). The RNA genome of arenaviruses is bi-segmented,
comprising a large (L) and a small (S) segment that each codes for
two proteins in ambisense coding strategy [4,5]. Despite this
coding strategy, the Arenaviridae are classified together with the
families Orthomyxoviridae and Bunyaviridae as segmented single-
strand, negative sense RNA viruses.
The South American hemorrhagic fever viruses Junin (JUNV;
[6,7]), Machupo (MACV; [8]), Guanarito (GTOV; [9]) and Sabia
virus (SABV, [10]), and the African Lassa virus (LASV [11]), are
restricted to biosafety level 4 (BSL-4) containment due to their
associated aerosol infectivity and rapid onset of severe disease.
With the possible exception of NW Tacaribe virus (TCRV; [12]),
which has been isolated from bats (Artibeus spp.), individual
arenavirus species are commonly transmitted by specific rodent
species wherein the capacity for persistent infection without overt
disease suggests long evolutionary adaptation between the agent
and its host [1,13–16]. Whereas NW arenaviruses are associated
with rodents in the Sigmodontinae subfamily of the family Cricetidae,
OW arenaviruses are associated with rodents in the Murinae
subfamily of the family Muridae.
Humans are most frequently infected through contact with
infected rodent excreta, commonly via inhalation of dust or
aerosolized virus-containing materials, or ingestion of contami-
nated foods [13]; however, transmission may also occur by
inoculation with infected body fluids and tissue transplantation
[17–19]. LCMV, which is spread by the ubiquitous Mus musculus as
host species and hence found world-wide, causes symptoms in
humans that range from asymptomatic infection or mild febrile
illness to meningitis and encephalitis [13]. LCMV infection is only
rarely fatal in immunocompetent adults; however, infection during
pregnancy bears serious risks for mother and child and frequently
results in congenital abnormalities. The African LASV, which has
its reservoir in rodent species of the Mastomys genus, causes an
estimated 100,000–500,000 human infections per year in West
African countries (Figure 1). Although Lassa fever is typically sub-
clinical or associated with mild febrile illness, up to 20% of cases
may have severe systemic disease culminating in fatal outcome
[20,21]. Three other African arenaviruses are not known to cause
human disease: Ippy virus (IPPYV; [22,23]), isolated from
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Praomys spp. in the Central African Republic (CAR); and Mopeia
virus (MOPV) that like LASV is associated with members of the
genus Mastomys, and was reported from Mozambique [25] and
Zimbabwe [26], although antibody studies suggest that MOPV
and LASV may also circulate in CAR [27] where the geographies
of these viruses appear to overlap (Figure 1). Up to present, there
have been no published reports of severe human disease associated
with arenaviruses isolated from southern Africa.
In September 2008 an outbreak of unexplained hemorrhagic
fever was reported in South Africa [28]. The index patient was
airlifted in critical condition from Zambia on September 12 to a
clinic in Sandton, South Africa, after infection from an
unidentified source. Secondary infections were recognized in a
paramedic (case 2) who attended the index case during air transfer
from Zambia, in a nurse (case 3) who attended the index case in
the intensive care unit in South Africa, and in a member of the
hospital staff (case 4) who cleaned the room after the index case
died on September 14. One case of tertiary infection was recorded
in a nurse (case 5) who attended case 2 after his transfer from
Zambia to Sandton on September 26, one day before barrier
nursing was implemented. The course of disease in cases 1 through
4 was fatal; case 5 received ribavirin treatment and recovered. A
detailed description of clinical and epidemiologic data, as well as
immunohistological and PCR analyses that indicated the presence
of an arenavirus, are reported in a parallel communication
(Paweska et al., Emerg. Inf. Dis., submitted). Here we report
detailed genetic analysis of this novel arenavirus.
Results/Discussion
Rapid identification of a novel pathogen through
unbiased pyrosequencing
RNA extracts from two post-mortem liver biopsies (cases 2 and
3) and one serum sample (case 2) were independently submitted
for unbiased high-throughput pyrosequencing. The libraries
yielded between 87,500 and 106,500 sequence reads. Alignment
of unique singleton and assembled contiguous sequences to the
GenBank database (http://www.ncbi.nlm.nih.gov/Genbank) us-
ing the Basic Local Alignment Search Tool (blastn and blastx;
[29]) indicated coverage of approximately 5.6 kilobases (kb) of
sequence distributed along arenavirus genome scaffolds: 2 kb of S
segment sequence in two fragments, and 3.6 kb of L segment
sequence in 7 fragments (Figure 2). The majority of arenavirus
sequences were obtained from serum rather than tissue, potentially
reflecting lower levels of competing cellular RNA in random
amplification reactions.
Full genome characterization of a newly identified
arenavirus
Sequence gaps between the aligned fragments were rapidly
filled by specific PCR amplification with primers designed on the
pyrosequence data at both, CU and CDC. Terminal sequences
were added by PCR using a universal arenavirus primer, targeting
the conserved viral termini (59-CGC ACM GDG GAT CCT
AGG C, modified from [30]) combined with 4 specific primers
positioned near the ends of the 2 genome segments. Overlapping
primer sets based on the draft genome were synthesized to
facilitate sequence validation by conventional dideoxy sequencing.
The accumulated data revealed a classical arenavirus genome
structure with a bi-segmented genome encoding in an ambisense
strategy two open reading frames (ORF) separated by an
intergenic stem-loop region on each segment (Figure 2) (GenBank
Accession numbers FJ952384 and FJ952385).
Our data represent genome sequences directly obtained from
liver biopsy and serum (case 2), and from cell culture isolates
obtained from blood at CDC (case 1 and 2), and from liver
biopsies at NICD (case 2 and 3). No sequence differences were
uncovered between virus detected in primary clinical material and
virus isolated in cell culture at the two facilities. In addition, no
changes were detected between each of the viruses derived from
these first three cases. This lack of sequence variation is consistent
with the epidemiologic data, indicating an initial natural exposure
of the index case, followed by a chain of nosocomial transmission
among subsequent cases.
Lujo virus (LUJV) is a novel arenavirus
Phylogenetic trees constructed from full L or S segment
nucleotide sequence show LUJV branching off the root of the
OW arenaviruses, and suggest it represents a highly novel genetic
lineage, very distinct from previously characterized virus species
and clearly separate from the LCMV lineage (Figure 3A and 3B).
No evidence of genome segment reassortment is found, given the
identical placement of LUJV relative to the other OW
arenaviruses based on S and L segment nucleotide sequences. In
addition, phylogenetic analysis of each of the individual ORFs
reveals similar phylogenetic tree topologies. A phylogenetic tree
constructed from deduced L-polymerase amino acid (aa) sequence
also shows LUJV near the root of the OW arenaviruses, distinct
from characterized species, and separate from the LCMV branch
(Figure 3C). A distant relationship to OW arenaviruses may also
be inferred from the analysis of Z protein sequence (Figure S1).
The NP gene sequence of LUJV differs from other arenaviruses
from 36% (IPPYV) to 43% (TAMV) at the nucleotide level, and
from 41% (MOBV/LASV) to 55% (TAMV) at the aa level (Table
S1). This degree of divergence is considerably higher than both,
proposed cut-off values within (,10–12%), or between (.21.5%)
OW arenavirus species [31,32], and indicates a unique phylo-
genitic position for LUJV (Figure 3D). Historically, phylogenetic
assignments of arenaviruses have been based on portions of the NP
gene [1,33], because this is the region for which most sequences
are known. However, as more genomic sequences have become
available, analyses of full-length GPC sequence have revealed
evidence of possible relationships between OW and NW
Author Summary
In September and October 2008, five cases of undiagnosed
hemorrhagic fever, four of them fatal, were recognized in
South Africa after air transfer of a critically ill index case
from Zambia. Serum and tissue samples from victims were
subjected to unbiased pyrosequencing, yielding within
72 hours of sample receipt, multiple discrete sequence
fragments that represented approximately 50% of a
prototypic arenavirus genome. Thereafter, full genome
sequence was generated by PCR amplification of inter-
vening fragments using specific primers complementary to
sequence obtained by pyrosequencing and a universal
primer targeting the conserved arenaviral termini. Phylo-
genetic analyses confirmed the presence of a new member
of the family Arenaviridae, provisionally named Lujo virus
(LUJV) in recognition of its geographic origin (Lusaka,
Zambia, and Johannesburg, South Africa). Our findings
enable the development of specific reagents to further
investigate the reservoir, geographic distribution, and
unusual pathogenicity of LUJV, and confirm the utility of
unbiased high throughput pyrosequencing for pathogen
discovery and public health.
A New Pathogenic Arenavirus from Southern Africa
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sequences are difficult to align some have pursued phylogenetic
analyses by combining the GPC signal peptide and the G2
sequence for phylogenetic analysis [16]. We included in our
analysis the chimeric signal/G2 sequence (Figure 3E) as well as the
receptor binding G1 portion (Figure 3F); both analyses highlighted
the novelty of LUJV, showing an almost similar distance from OW
as from NW viruses.
Protein motifs potentially relevant to LUJV biology
Canonical polymerase domains pre-A, A, B, C, D, and E [35–
37] are well conserved in the L ORF of LUJV (256 kDa, pI=6.4;
Figure 4). The Z ORF (10.5 kDa, pI=9.3) contains two late
domain motifs like LASV; however, in place of the PTAP motif
found in LASV, that mediates recognition of the tumor
susceptibility gene 101, Tsg101 [38], involved in vacuolar protein
sorting [39,40], LUJV has a unique Y77REL motif that matches
the YXXL motif of the retrovirus equine infectious anemia virus
[41], which interacts with the clathrin adaptor protein 2 (AP2)
complex [42]. A Tsg101-interacting motif, P90SAP, is found in
LUJV in position of the second late domain of LASV, PPPY,
which acts as a Nedd4-like ubiquitin ligase recognition motif [43].
The RING motif, containing conserved residue W44 [44], and the
conserved myristoylation site G2 are present [45–47] (Figure 4).
The NP of LUJV (63.1 kDa, pI=9.0) contains described aa motifs
that resemble mostly OW arenaviruses [48], including a cytotoxic
T-lymphocyte (CTL) epitope reported in LCMV (GVYMGNL;
[49]), corresponding to G122VYRGNL in LUJV, and a potential
antigenic site reported in the N-terminal portion of LASV NP
(RKSKRND; [50]), corresponding to R55KDKRND in LUJV
(Figure 4).
The GPC precursor (52.3 kDa, pI=9.0) is cotranslationally
cleaved into the long, stable signal peptide and the mature
glycoproteins G1 and G2 [51–54]. Based on analogy to LASV
[55] and LCMV [56], signalase would be predicted to cleave
between D58 and S59 in LUJV. However, aspartate and arginine
Figure 1. Geographic distribution of African arenaviruses. MOBV, MOPV, and IPPYV (blue) have not been implicated in human disease; LASV
(red) can cause hemorrhagic fever. The origin of the LUJV index and secondary and tertiary cases linked in the 2008 outbreak are indicated in gold.
doi:10.1371/journal.ppat.1000455.g001
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(23,21)-rule [57]; thus, cleavage may occur between S59 and S60 as
predicted by the SignalP algorithm. The putative 59 aa signal
peptide of LUJV displays a conserved G2, implicated in myristoyla-
tion in JUNV [58], however, it is followed in LUJV by a non-
standard valine residue in position +4, resembling non-standard
glycine residues found in Oliveros virus (OLVV [59]) and Latino
virus (LATV; http://www2.ncid.cdc.gov/arbocat/catalog-listing.
asp?VirusID=263&SI=1). Conservation is also observed for aa
residues P12 (except Amapari virus; AMAV [60]), E17 [61](except
Pirital virus; PIRV [62]), and N20 in hydrophobic domain 1, as well
as I32KGVFNLYK40SG, identified as a CTL epitope in LCMV
WE (I32KAVYNFATCG; [63]) (Figure 4).
Analogous to other arenaviruses, SKI-1/S1P cleavage C-
terminal of RKLM221 is predicted to separate mature G1 (162
aa, 18.9 kDa, pI=6.4) from G2 (233 aa, 26.8 kDa, pI=9.5)
[52,53,64]. G2 appears overall well conserved, including the
strictly conserved cysteine residues: 6 in the luminal domain, and 3
in the cytoplasmic tail that are included in a conserved zinc finger
motif reported in JUNV [65] (Figure 4). G2 contains 6 potential
glycosylation sites, including 2 strictly conserved sites, 2 semi-
conserved sites N335 (absent in LCMVs and Dandenong virus;
DANV [19]) and N352 (absent in LATV), and 2 unique sites in the
predicted cytoplasmic tail (Figure 4). G1 is poorly conserved
among arenaviruses [16], and G1 of LUJV is no exception, being
highly divergent from the G1 of the other arenaviruses, and
shorter than that of other arenaviruses. LUJV G1 contains 6
potential glycosylation sites in positions comparable to other
arenaviruses, including a conserved site N93HS (Figure 4), which is
shifted by one aa in a motif that otherwise aligns well with OW
arenaviruses and NW arenavirus clade A and C viruses. There is
no discernable homology to other arenavirus G1 sequences that
would point to usage of one of the two identified arenavirus
receptors; Alpha-dystroglycan (a-DG) [66] that binds OW
arenaviruses LASV and LCMV, and NW clade C viruses OLVV
and LATV [67], or transferrin receptor 1 (TfR1) that binds
pathogenic NW arenaviruses JUNV, MACV, GTOV, and SABV
[68] (Figure S2).
Figure 2. LUJV genome organization and potential secondary structure of intergenic regions. Open reading frames (ORF) for the
glycoprotein precursor GPC, the nucleoprotein NP, the matrix protein analog Z, and the polymerase L, and their orientation are indicated (A); blue
bars represent sequences obtained by pyrosequencing from clinical samples. Secondary structure predictions of intergenic regions (IR) for S (B, C) and
L segment sequence (D, E) in genomic (B, D) and antigenomic orientation (C, E) were analyzed by mfold; shading indicates the respective termination
codon (opal, position 1), and its reverse-complement, respectively.
doi:10.1371/journal.ppat.1000455.g002
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PLoS Pathogens | www.plospathogens.org 4 May 2009 | Volume 5 | Issue 5 | e1000455Figure 3. Phylogenetic analyses of LUJV. Phylogenetic relationships of LUJV were inferred based on full L (A) and S segment nucleotide
sequence (B), as well as on deduced amino acid sequences of L (C), NP (D), Signal/G2 (E) and G1 (F) ORF’s. Phylogenies were reconstructed by
neighbor-joining analysis applying a Jukes-Cantor model; the scale bar indicates substitutions per site; robust boostrap support for the positioning of
LUJV was obtained in all cases (.98% of 1000 pseudoreplicates). GenBank Accession numbers for reference sequences are: ALLV CLHP2472
(AY216502, AY012687); AMAV BeAn70563 (AF512834); BCNV AVA0070039 (AY924390, AY922491), A0060209 (AY216503); CATV AVA0400135
(DQ865244), AVA0400212 (DQ865245); CHPV 810419 (EU, 260464, EU260463); CPXV BeAn119303 (AY216519, AF512832); DANV 0710-2678
(EU136039, EU136038); FLEV BeAn293022 (EU627611, AF512831); GTOV INH-95551 (AY358024, AF485258), CVH-960101 (AY497548); IPPYV
DakAnB188d (DQ328878, DQ328877); JUNV MC2 (AY216507, D10072), XJ13 (AY358022, AY358023), CbalV4454 (DQ272266); LASV LP (AF181853),
803213 (AF181854), Weller (AY628206), AV (AY179171, AF246121), Z148 (AY628204, AY628205), Josiah (U73034, J043204), NL (AY179172, AY179173);
LATV MARU10924 (EU627612, AF485259); LCMV Armstrong (AY847351), ARM53b (M20869), WE (AF004519, M22138), Marseille12 (DQ286932,
DQ286931), M1 (AB261991); MACV Carvallo (AY619642, AY619643), Chicava (AY624354, AY624355), Mallele (AY619644, AY619645), MARU222688
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virus that is only distantly related to known arenaviruses. Sequence
divergence is evident across the whole genome, but is most
pronounced in the G1 protein encoded by the S segment, a region
implicated in receptor interactions. Reassortment of S and L
segments leading to changes in pathogenicity has been described
in cultured cells infected with different LCMV strains [69], and
between pathogenic LASV and nonpathogenic MOPV [70]. We
find no evidence to support reassortment of the LUJV L or S
genome segment (Figure 3A and 3B). Recombination of
glycoprotein sequence has been recognized in NW arenaviruses
[14,16,33,34,71–73], resulting in the division of the complex into
four sublineages: lineages A, B, C, and an A/recombinant lineage
that forms a branch of lineage A when NP and L sequence is
considered (see Figure 3C and 3D), but forms an independent
branch in between lineages B and C when glycoprotein sequence
is considered (see Figure 3D). While recombination cannot be
excluded in case of LUJV, our review of existing databases reveals
no candidate donor for the divergent GPC sequence. To our
knowledge is LUJV the first hemorrhagic fever-associated
arenavirus from Africa identified in the past 3 decades. It is also
the first such virus originating south of the equator (Figure 1). The
International Committee on the Taxonomy of Viruses (ICTV)
defines species within the Arenavirus genus based on association
with a specific host, geographic distribution, potential to cause
human disease, antigenic cross reactivity, and protein sequence
similarity to other species. By these criteria, given the novelty of its
presence in southern Africa, capacity to cause hemorrhagic fever,
and its genetic distinction, LUJV appears to be a new species.
Materials and Methods
Sequencing
Clinical specimens were inactivated in TRIzol (liver tissue,
100 mg) or TRIzol LS (serum, 250 ml) reagent (Invitrogen,
Carlsbad, CA, USA) prior to removal from BSL-4 containment.
Total RNAextractsweretreated with DNaseI (DNA-free,Ambion,
Austin, TX, USA) and cDNA generated by using the Superscript II
system (Invitrogen) and 100–500 ng RNA for reverse transcription
primed with random octamers that were linked to an arbitrary,
defined 17-mer primer sequence [74]. The resulting cDNA was
treated with RNase H and then randomly amplified by the
polymerase chain reaction (PCR; [75]); applying a 9:1 mixture of a
primer corresponding to the defined 17-mer sequence, and the
random octamer-linked 17-mer primer, respectively [74]. Products
.70 base pairs (bp) wereselected by columnpurification(MinElute,
Qiagen, Hilden, Germany) and ligated to specific linkers for
sequencing on the 454 Genome Sequencer FLX (454 Life Sciences,
Branford, CT, USA) without fragmentation of the cDNA
[19,76,77]). Removal of primer sequences, redundancy filtering,
Figure 4. Schematic of conserved protein motifs. Conservation of LUJV amino acid motifs with respect to all other (green highlight), to OW
(yellow highlight), or to NW (blue highlight) arenaviruses is indicated; grey highlight indicates features unique to LUJV. Polymerase motifs pre-A
(L1142), A (N1209), B (M1313), C (L1345), D (Q1386), and E (C1398) are indicated for the L ORF; potential myristoylation site G2, the RING motif H34/C76, and
potential late domains YXXL an PSAP are indicated for the Z ORF; and myristoylation site G2, posttranslational processing sites for signalase (S59/S60)
and S1P cleavage (RKLM221), CTL epitope (I32), zinc finger motif P415/G440, as well as conserved cysteine residues and glycosylations sites (Y) are
indicated for GPC. * late domain absent in NW viruses and DANV; { PSAP or PTAP in NW viruses, except in PIRV and TCRV (OW viruses: PPPY); # Gi n
all viruses except LCMV (=A); { D in NW clade A only; 1 conserved with respect to OW, and NW clade A and C; HD, hydrophobic domain; TM,
transmembrane anchor.
doi:10.1371/journal.ppat.1000455.g004
(AY922407), 9530537 (AY571959); MOBV ACAR3080MRC5P2 (DQ328876, AY342390); MOPV AN20410 (AY772169, AY772170), Mozambique
(DQ328875, DQ328874); NAAV AVD1240007 (EU123329); OLVV 3229-1 (AY216514, U34248); PARV 12056 (EU627613, AF485261); PICV (K02734),
MunchiqueCoAn4763 (EF529745, EF529744), AN3739 (AF427517); PIRV VAV-488 (AY216505, AF277659); SABV SPH114202 (AY358026, U41071); SKTV
AVD1000090 (EU123328); TAMV W10777 (EU627614, AF512828); TCRV (J04340, M20304); WWAV AV9310135 (AY924395, AF228063).
doi:10.1371/journal.ppat.1000455.g003
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accessible through the analysis applications at the GreenePortal
website (http://156.145.84.111/Tools).
Conventional PCRs at CU were performed with HotStar
polymerase (Qiagen) according to manufacturer’s protocols on
PTC-200 thermocyclers (Bio-Rad, Hercules, CA, USA): an
enzyme activation step of 5 min at 95uC was followed by 45
cycles of denaturation at 95uC for 1 min, annealing at 55uC for
1 min, and extension at 72uC for 1 to 3 min depending on the
expected amplicon size. A two-step RT-PCR protocol was also
followed at CDC using Invitrogen’s Thermoscript RT at 60
degrees for 30 min followed by RNase H treatment for 20 min.
cDNA was amplified using Phusion enzyme with GC Buffer
(Finnzymes, Espoo, Finland) and 3% DMSO with an activation
step at 98uC for 30 sec, followed by the cycling conditions of 98uC
for 10 sec, 58uC for 20 sec, and 72uC for 1 min for 35 cycles and a
5 min extension at 72uC. Specific primer sequences are available
upon request. Amplification products were run on 1% agarose
gels, purified (MinElute, Qiagen), and directly sequenced in both
directions with ABI PRISM Big Dye Terminator 1.1 Cycle
Sequencing kits on ABI PRISM 3700 DNA Analyzers (Perkin-
Elmer Applied Biosystems, Foster City, CA).
Sequence analyses
Programs of the Wisconsin GCG Package (Accelrys, San Diego,
CA, USA) were used for sequence assembly and analysis; percent
sequence difference was calculated based on Needleman-Wunsch
alignments (gap open/extension penalties 15/6.6 for nucleotide and
10/0.1 for aa alignments; EMBOSS [78]), using a Perl script to
iterate the process for all versus all comparison. Secondary RNA
structure predictions were performed with the web-based version of
mfold (http://mfold.bioinfo.rpi.edu); data were exported as .ct files
and layout and annotation was done with CLC RNA Workbench
(CLC bio, A ˚rhus, Denmark). Protein topology and targeting
predictions were generated by employing SignalP, and NetNGlyc,
TMHMM (http://www.cbs.dtu.dk/services), the web-based ver-
sion of TopPred (http://mobyle.pasteur.fr/cgi-bin/portal.py?form
=toppred), and Phobius (http://phobius.sbc.su.se/). Phylogenetic
analyses were performed using MEGA software [79].
Supporting Information
Figure S1 Phylogenetic tree based on deduced Z amino acid
sequence. In contrast to phylogenetic trees obtained with the other
ORFs (Figure 2), poor bootstrap support (43% of 1,000
pseudoreplicates) for the branching of LUJV off the LCMV clade
was obtained with Z ORF sequence. For GenBank accession
numbers see Figure 2.
Found at: doi:10.1371/journal.ppat.1000455.s001 (0.44 MB TIF)
Figure S2 Pairwise sliding-window distance analysis of GPC
sequence. LUJV and members of the OW (LASV, MOPV,
IPPYV, LCMV, DANV) and NW (GTOV, CPXV, BNCV,
PIRV, OLVV, SABV, MACV) arenavirus complex were
compared using LASV NL (A) or GTOV CVH (B) as query (10
aa step; 80 aa window).
Found at: doi:10.1371/journal.ppat.1000455.s002 (4.21 MB TIF)
Table S1 Pairwise nucleotide and amino acid differences
between LUJV and other OW and NW arenaviruses. * NAAV,
North American arenavirus. { Values ,30% (amino acid) or
,33% (nucleotide) are highlighted in green.
Found at: doi:10.1371/journal.ppat.1000455.s003 (0.20 MB
DOC)
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